Citius Pharmaceuticals 8-K Filing: Key Insights from January 7, 2025

Here are the key insights extracted from the provided section of the financial report:

Filing Type and Date: The document is an 8-K filing dated January 7, 2025. An 8-K is typically used by publicly traded companies to report major events that shareholders should know about.
Entity Information:

Company Name: Citius Pharmaceuticals, Inc.
CIK: 0001506251 (Central Index Key used by the SEC)
Entity Type: The company operates in the pharmaceutical sector.
State of Incorporation: Nevada (NV)
IRS Number: 27-3425913

Address:

11 Commerce Drive, 1st Floor, Cranford, NJ 07016
Contact Number: 908-967-6677

Securities Information:

Type of Security: Common stock
Par Value: $0.001
Ticker Symbol: CTXR
Exchange: NASDAQ

Reporting Unit:

The financial information is reported in U.S. Dollars (USD) and in shares.

Context Information:

The context indicates that the information reported is as of January 7, 2025, which is the same as the start and end date, suggesting it may be a snapshot of information rather than a financial summary over a period.

Measurement Units:

The report uses various measurement units, including USD for currency and shares for stock measurement.

Overall, this document appears to provide a snapshot of Citius Pharmaceuticals, Inc. as of a specific date, likely related to an important event or announcement that warranted an 8-K filing. Further details may be necessary to understand the specific nature of the event reported.